This announcement is a separate document:
维康药业：关于收到银黄滴丸Ⅱb期临床试验总结报告的提示性公告
Zhejiang Wecome Pharmaceutical: Notice regarding the receipt of the summary report of the phase IIb clinical trial of Silver Yellow Pill.
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.